LyGenesis
0 followers
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end-stage liver disease.
Org chart
Michael Hufford
Collapse
Eric Lagasse
CSO
Jacqueline Jeha, MPH
Director of Clinical Operations and Corporate Development
Jennifer Taylor
Director, Clinical Operations
Paulo Fontes, MD, FACS
Co-founder & Medical Advisor
